The American Psychiatric Association has recently published the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The DSM-IV category "Dementia, Delirium, Amnestic, and Other Cognitive Disorders" has undergone extensive revision. DSM-5 has renamed this category as "Neurocognitive Disorders" (NCD), which now covers three entities: delirium, major NCD, and mild NCD. The DSM-IV version of mild NCD resembles the DSM-5 version in name only. DSM-IV defined mild NCD based on a single criterion, whereas DSM-5 defines mild NCD by using several cognitive and related criteria. The main difference between mild NCD and the Key International Symposium criteria of mild cognitive impairment (MCI) is that the research work that led to the construct of MCI primarily involved elderly study participants (even though age was not part of the definition of MCI), whereas mild NCD includes acquired cognitive disorders of all age groups. DSM-5 essentially discusses the epidemiology and diagnostic markers of mild NCD by drawing congruence between MCI and mild NCD. The DSM-5 definition of mild NCD is anchored on four criteria and two specifiers. The four criteria refer to cognitive changes, functional activities, and exclusion of delirium and competing mental disorders. The two specifiers are the presumed etiologies of mild NCD and the presence or absence of behavioral problems. While the category "mild NCD" may improve reliability of diagnoses, it has yet to withstand scientific scrutiny to be considered a valid construct. This article reviews the DSM-5 criteria for mild NCD, compares them with the Key International Symposium MCI criteria, and discusses the pros and cons of the mild NCD construct.

From the International Clinical Research Center Brno Czech Republic

See more in PubMed

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed Arlington, VA: APA, 2013.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed Washington, DC: APA, 1994.

Sachdev PS, Blacker D, Blazer DG, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol 2014; 10: 634– 42. PubMed

Ganguli M, Blacker D, Blazer DG, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry 2011; 19: 205– 10. PubMed PMC

Ganguli M. Can the DSM-5 framework enhance the diagnosis of MCI? Neurology 2013; 81: 2045– 50. PubMed PMC

Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240– 6. PubMed

Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183– 94. PubMed

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303– 8. PubMed

Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol 2009; 66: 1447– 55. PubMed PMC

Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement 2011; 7: 270– 9. PubMed PMC

Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med 2014; 275: 214– 28. PubMed PMC

Blazer D. Neurocognitive disorders in DSM-5. Am J Psychiatry 2013; 170: 585– 7. PubMed

Reisberg B, Ferris SH, de Leon MJ, et al. Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment and primary degenerative dementia of the Alzheimer type. Drug Dev Res 1988; 15: 101– 14.

Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6: 63– 8. PubMed

Kral VA. Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962; 86: 257– 60. PubMed PMC

Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Brit J Psychiatry 1982; 140: 566– 72. PubMed

Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 1997; 45: 321– 8. PubMed

Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change—report of a National Institute of Mental Health work group. Dev Neuropsych 1986; 2: 261– 76.

Blackford RC, La Rue A. Criteria for diagnosing age-associated memory impairment: proposed improvements from the field. Dev Neuropsychol 1989; 5: 295– 306.

Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793– 6. PubMed

Smith GE, Rush BK. Normal aging and mild cognitive impairment. In: Attix DK, Welsh-Bohmer KA, eds. Geriatric neuropsychology: assessment and intervention. New York: Guilford, 2006.

Geda YE, Nedelska Z. Mild cognitive impairment: a subset of minor neurocognitive disorder? Am J Geriatr Psychiatry 2012; 20: 821– 6. PubMed PMC

Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 2379– 88. PubMed

Morris JC, Cummings J. Mild cognitive impairment (MCI) represents early-stage Alzheimer’s disease. J Alzheimers Dis 2005; 7: 235– 9;discussion 55–62. PubMed

Morris JC. Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. Arch Neurol 2006; 63: 15– 6. PubMed

Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58: 397– 405. PubMed

Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer’s disease? Lancet Neurol 2004; 3: 246– 8. PubMed

Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734– 46. PubMed

Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 280– 92. PubMed PMC

Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189– 98. PubMed

Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695– 9. PubMed

Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078– 85. PubMed

Kokmen E, Naessens JM, Offord KP. A short test of mental status: description and preliminary results. Mayo Clin Proc 1987; 62: 281– 8. PubMed

Caselli RJ, Dueck AC, Osborne D, et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 2009; 361: 255– 63. PubMed PMC

Verghese J, Lipton RB, Katz MJ, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003; 348: 2508– 16. PubMed

Verghese J, LeValley A, Derby C, et al. Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology 2006; 66: 821– 7. PubMed PMC

Geda YE, Roberts RO, Knopman DS, et al. Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol 2010; 67: 80– 6. PubMed PMC

Rey A. L’examen clinique en psychologie. Paris: Presses universitaires de France, 1964.

Wechsler D. Wechsler Memory Scale–Revised. New York: Psychological Corporation, 1987.

Kaplan E, Goodglass H, Brand S. Boston Naming Test. Philadelphia: Lea & Febiger, 1983.

Lucas JA, Ivnik RJ, Smith GE, et al. Mayo’s older Americans normative studies: category fluency norms. J Clin Exp Neuropsychol 1998; 20: 194– 200. PubMed

Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271– 6.

Wechsler D. Wechsler Adult Intelligence Scale–Revised. New York: Psychological Corporation, 1981.

Jack CR, Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 2010; 9: 119– 28. PubMed PMC

Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306– 19. PubMed

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228– 34. PubMed

Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004; 56: 27– 35. PubMed PMC

Dickerson BC, Stoub TR, Shah RC, et al. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 2011; 76: 1395– 402. PubMed PMC

Jack CR, Jr, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55: 484– 9. PubMed PMC

Jack CR, Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397– 403. PubMed PMC

Ganguli M, Dodge HH, Shen C, DeKosky ST. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004; 63: 115– 21. PubMed

Hanninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H. Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 2002; 106: 148– 54. PubMed

Petersen RC, Roberts RO, Knopman DS, et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 2010; 75: 889– 97. PubMed PMC

Larrieu S, Letenneur L, Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002; 59: 1594– 9. PubMed

Sachs-Ericsson N, Blazer DG. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment. Aging Ment Health 2015; 19: 2– 12. PubMed

Rabins PV, Lyketsos CG. A commentary on the proposed DSM revision regarding the classification of cognitive disorders. Am J Geriatr Psychiatry 2011; 19: 201– 4. PubMed

Looi JC, Velakoulis D. Major and minor neurocognitive disorders in DSM-5: the difference between the map and the terrain. Aust N Z J Psychiatry 2014; 48: 284– 6. PubMed

Mitchell AJ. Redefining the syndrome of cognitive impairment in DSM-5. Aust N Z J Psychiatry 2013; 47: 779– 80. PubMed

Snelgrove TA, Hasnain M. A concern about the proposed DSM-V criteria reclassifying cognitive disorders. Am J Geriatr Psychiatry 2012; 20: 543. PubMed

Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456– 77. PubMed PMC

Lopez-Anton R, Santabarbara J, De-la-Camara C, et al. Mild cognitive impairment diagnosed with the new DSM-5 criteria: prevalence and associations with non-cognitive psychopathology. Acta Psychiatr Scand 2015; 131: 29– 39. PubMed

Breitner JC. Observations on DSM-5 mild neurocognitive disorder vs. its predecessor, mild cognitive impairment. Acta Psychiatr Scand 2015; 131: 15– 7. PubMed